Holen Sie sich die Stockscreener-App
5.92
2.06%
-0.14
Schlusskurs vom Vortag:
$6.06
Offen:
$6.09
24-Stunden-Volumen:
87,509
Relative Volume:
0.92
Marktkapitalisierung:
$71.85M
Einnahmen:
$58.44M
Nettoeinkommen (Verlust:
$-34.28M
KGV:
-2.0418
EPS:
-2.8994
Netto-Cashflow:
$-14.91M
1W Leistung:
+1.11%
1M Leistung:
-49.70%
6M Leistung:
-50.87%
1J Leistung:
-57.15%
1-Tages-Spanne:
$5.85
$6.09
1-Wochen-Bereich:
$5.80
$6.50
52-Wochen-Spanne:
$5.35
$14.31
Lensar Inc Stock (LNSR) Company Profile
Firmenname
Lensar Inc
Sektor
Branche
Telefon
888-536-7271
Adresse
2800 DISCOVERY DRIVE, ORLANDO
Compare LNSR vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
5.94 | 73.30M | 58.44M | -34.28M | -14.91M | -2.8994 |
ABT
Abbott Laboratories
|
102.15 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
332.19 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.28 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.53 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.07 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-02-24 | Eingeleitet | SVB Leerink | Outperform |
Lensar Inc Aktie (LNSR) Neueste Nachrichten
How The LENSAR (LNSR) Story Is Shifting After The Failed Alcon Deal And Target Reset - Yahoo Finance
Discipline and Rules-Based Execution in LNSR Response - Stock Traders Daily
LENSAR, Inc. (NASDAQ:LNSR) Q4 2025 Earnings Call Transcript - Insider Monkey
LENSAR Inc (LNSR) Q4 2025 Earnings Call Highlights: Navigating G - gurufocus.com
LENSAR : LNSR Corporate Presentation March 2026 - marketscreener.com
Lensar Faces Heightened Litigation Risk as Shareholders Challenge Merger Disclosures in Delaware - tipranks.com
BTIG Upgrades LENSAR, Inc. (LNSR) to Buy March 2026 - Meyka
Investment Recap: Is LENSAR Inc a strong candidate for buy and hold2026 Institutional Moves & Stock Timing and Entry Methods - baoquankhu1.vn
Lensar Earnings Call: Recurring Revenue Shines Amid Disruption - tipranks.com
LNSR SEC FilingsLensar Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Lake Street upgrades Lensar stock rating to buy after merger termination - Investing.com Australia
LENSAR (NASDAQ:LNSR) Upgraded at Lake Street Capital - MarketBeat
LENSAR, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
LENSAR (LNSR) price target decreased by 16.67% to 12.75 - MSN
LENSAR Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update - bitget.com
LENSAR Reports Strong 2025 Results: ALLY Robotic Cataract Laser Adoption Grows, Recurring Revenue Hits $46.3M - Minichart
LENSAR (LNSR) leans on ALLY robotic cataract laser amid expanding global surgery demand - Stock Titan
Lensar outlines 46%–49% gross margin forecast for 2026 as it restarts growth after Alcon deal termination - MSN
BTIG cuts Lensar stock price target to $7 on weak results - Investing.com Canada
BTIG cuts Lensar stock price target to $7 on weak results By Investing.com - Investing.com South Africa
Alcon Inc Stock Faces Patent Setback and Merger Termination: Key Implications for NYSE:ALC Investors - AD HOC NEWS
Growth Report: Should I average down on LENSAR Inc stockTrade Ideas & High Conviction Buy Zone Picks - baoquankhu1.vn
LENSAR ($LNSR) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
LNSR: Recurring revenue and procedure volumes grew strongly in 2025, with positive adjusted EBITDA - TradingView
LENSAR Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: LENSAR Q4 2025 results show mixed signals By Investing.com - Investing.com Canada
LENSAR earnings missed by $0.05, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: LENSAR Q4 2025 results show mixed signals - Investing.com
LENSAR (NASDAQ:LNSR) Releases Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
LENSAR, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Q4 2025 LENSAR Inc Earnings Call Transcript - gurufocus.com
LENSAR (LNSR) Advances in Robotic Laser Cataract Surgery with St - gurufocus.com
Lensar, Inc. (LNSR) Reports Q4 Earnings - AlphaStreet
LENSAR reports FY2025 revenue $58.4M, recurring revenue $46.3M and 79% recurring mix - TradingView
LENSAR® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update - The Manila Times
Earnings To Watch: LENSAR Inc (LNSR) Reports Q4 2025 Result - gurufocus.com
LENSAR, Inc. Stock Plummets to New 52-Week Low of $5.35 - Markets Mojo
Lensar stock slumps after hours on ending merger deal with Alcon over FTC pushback - MSN
LENSAR Inc Stock: Navigating Post-Merger Challenges and Future Growth in Ophthalmic Innovation - AD HOC NEWS
LENSAR, Inc. Stock Plummets to New 52-Week Low of $5.50 - Markets Mojo
Volume Report: What are analysts price targets for LENSAR IncQuarterly Portfolio Summary & Weekly High Momentum Picks - baoquankhu1.vn
LENSAR, Inc. Hits New 52-Week Low at $5.52 Amidst Market Struggles - Markets Mojo
Alcon Inc stock faces uncertainty as Lensar merger collapses, pivots to organic growth strategy - AD HOC NEWS
LENSAR Inc stock plunges as Alcon terminates merger over FTC antitrust block - AD HOC NEWS
LENSAR Inc stock faces prolonged uncertainty as Alcon merger awaits FTC approval amid regulatory del - AD HOC NEWS
LENSAR Inc stock faces uncertainty as Alcon merger awaits final regulatory approval amid pending FTC - AD HOC NEWS
LENSAR, Inc. Stock Plummets to New 52-Week Low of $5.82 - Markets Mojo
Alcon Inc stock faces uncertainty as Lensar merger collapses, prompting strategic pivot to core eye - AD HOC NEWS
Behavioral Patterns of LNSR and Institutional Flows - Stock Traders Daily
LENSAR, Inc. Stock Plummets to New 52-Week Low of $5.83 - Markets Mojo
Finanzdaten der Lensar Inc-Aktie (LNSR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.25%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):